TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
HUMAN_PWY-6371	superpathway of inositol phosphate compounds	0.0248141264094469	-3.69634217469512	66	16	0.119402985074627	134	903	51763,23533,5290,9807,51196,5728,23262,113026,3705,3635,64419,23396,8396,8503,55361,5330	INPP5K,PIK3R5,PIK3CA,IP6K1,PLCE1,PTEN,PPIP5K2,PLCD3,ITPK1,INPP5D,MTMR14,PIP5K1C,PIP4K2B,PIK3R3,PI4K2A,PLCB2
META_PWY-5667	CDP-diacylglycerol biosynthesis I	0.0254620520275146	-3.6705660910051	5	3	0.0223880597014925	134	903	10555,56894,56895	AGPAT2,AGPAT3,AGPAT4
META_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.0254620520275146	-3.6705660910051	5	3	0.0223880597014925	134	903	2589,56913,10331	GALNT1,C1GALT1,B3GNT3
META_PWY-6569	chondroitin sulfate biosynthesis	0.0383880155405662	-3.26000996339808	18	6	0.0447761194029851	134	903	9469,27087,50515,10090,55790,337876	CHST3,B3GAT1,CHST11,UST,CSGALNACT1,CHSY3
HUMAN_PWY3DJ-12	ceramide de novo biosynthesis	0.0454475823850705	-3.09119565262117	6	3	0.0223880597014925	134	903	10715,123099,9517	CERS1,DEGS2,SPTLC2
META_PWY-6571	dermatan sulfate biosynthesis	0.0577655984099915	-2.85136186371379	15	5	0.0373134328358209	134	903	10090,55790,337876,29940,27087	UST,CSGALNACT1,CHSY3,DSE,B3GAT1
HUMAN_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.0635550826741849	-2.75584830540739	25	7	0.0522388059701493	134	903	11227,56913,2589,6483,10331,55568,8693	GALNT5,C1GALT1,GALNT1,ST3GAL2,B3GNT3,GALNT10,GALNT4
HUMAN_TRIGLSYN-PWY	triacylglycerol biosynthesis	0.0635550826741849	-2.75584830540739	25	7	0.0522388059701493	134	903	64748,137964,10555,8612,56895,56894,9890	PLPPR2,GPAT4,AGPAT2,PLPP2,AGPAT4,AGPAT3,PLPPR4
META_PWY-6567	chondroitin sulfate biosynthesis (late stages)	0.0710477767894778	-2.64440271571708	7	3	0.0223880597014925	134	903	9469,50515,10090	CHST3,CHST11,UST
HUMAN_PWY3DJ-11281	sphingomyelin metabolism/ceramide salvage	0.0710477767894778	-2.64440271571708	7	3	0.0223880597014925	134	903	259230,339221,55512	SGMS1,ENPP7,SMPD3
HUMAN_PWY-6569	chondroitin sulfate biosynthesis	0.0743197267209656	-2.59937886154244	16	5	0.0373134328358209	134	903	55790,10090,50515,27087,9469	CSGALNACT1,UST,CHST11,B3GAT1,CHST3
HUMAN_PWY-6571	dermatan sulfate biosynthesis	0.0879408112852952	-2.43109128983087	12	4	0.0298507462686567	134	903	55790,10090,27087,29940	CSGALNACT1,UST,B3GAT1,DSE
HUMAN_PWY-6567	chondroitin sulfate biosynthesis (late stages)	0.101648009163712	-2.28623932430654	8	3	0.0223880597014925	134	903	10090,50515,9469	UST,CHST11,CHST3
HUMAN_PWY66-423	fructose 2,6-bisphosphate synthesis	0.107039353213525	-2.23455872509502	4	2	0.0149253731343284	134	903	5209,5208	PFKFB3,PFKFB2
META_PWY-7434	terminal O-glycans residues modification	0.107039353213525	-2.23455872509502	4	2	0.0149253731343284	134	903	6487,10690	ST3GAL3,FUT9
META_PWY66-423	fructose 2,6-bisphosphate biosynthesis	0.107039353213525	-2.23455872509502	4	2	0.0149253731343284	134	903	5208,5209	PFKFB2,PFKFB3
META_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.107039353213525	-2.23455872509502	4	2	0.0149253731343284	134	903	29940,10090	DSE,UST
HUMAN_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.107039353213525	-2.23455872509502	4	2	0.0149253731343284	134	903	10090,29940	UST,DSE
HUMAN_ASPARAGINE-DEG1-PWY-1	asparagine degradation	0.107039353213525	-2.23455872509502	4	2	0.0149253731343284	134	903	80150,374569	ASRGL1,ASPG
HUMAN_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.111493406602776	-2.19378982343781	23	6	0.0447761194029851	134	903	113026,55361,8396,5330,51196,23396	PLCD3,PI4K2A,PIP4K2B,PLCB2,PLCE1,PIP5K1C
META_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.112938644115529	-2.18091058016166	13	4	0.0298507462686567	134	903	55361,23396,51196,5330	PI4K2A,PIP5K1C,PLCE1,PLCB2
HUMAN_LIPASYN-PWY	phospholipases	0.124179543398994	-2.08602682998085	29	7	0.0522388059701493	134	903	113026,122618,255189,151056,5338,5330,51196	PLCD3,PLD4,PLA2G4F,PLB1,PLD2,PLCB2,PLCE1
META_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.13647643007083	-1.99160335274068	9	3	0.0223880597014925	134	903	5330,51196,64419	PLCB2,PLCE1,MTMR14
HUMAN_PWY-5667	CDP-diacylglycerol biosynthesis	0.137402693771935	-1.98483929405903	19	5	0.0373134328358209	134	903	8760,10555,137964,56895,56894	CDS2,AGPAT2,GPAT4,AGPAT4,AGPAT3
META_HISHP-PWY	L-histidine degradation VI	0.148394241417648	-1.90788275346506	1	1	0.00746268656716418	134	903	3034	HAL
HUMAN_BGALACT-PWY	lactose degradation III	0.148394241417648	-1.90788275346506	1	1	0.00746268656716418	134	903	2720	GLB1
META_PWY-7435	mucin core 3 and core 4 O-glycosylation	0.148394241417648	-1.90788275346506	1	1	0.00746268656716418	134	903	2589	GALNT1
HUMAN_PWY-5963	thio-molybdenum cofactor biosynthesis	0.148394241417648	-1.90788275346506	1	1	0.00746268656716418	134	903	55034	MOCOS
META_PWY-6134	L-tyrosine biosynthesis IV	0.148394241417648	-1.90788275346506	1	1	0.00746268656716418	134	903	5053	PAH
META_PWY-6535	4-aminobutanoate degradation I	0.148394241417648	-1.90788275346506	1	1	0.00746268656716418	134	903	18	ABAT
HUMAN_PWY-40	putrescine biosynthesis II	0.148394241417648	-1.90788275346506	1	1	0.00746268656716418	134	903	113451	AZIN2
META_PWY-40	putrescine biosynthesis I	0.148394241417648	-1.90788275346506	1	1	0.00746268656716418	134	903	113451	AZIN2
HUMAN_PWY-4101	sorbitol degradation I	0.148394241417648	-1.90788275346506	1	1	0.00746268656716418	134	903	6652	SORD
HUMAN_PWY-6535	4-aminobutyrate degradation	0.148394241417648	-1.90788275346506	1	1	0.00746268656716418	134	903	18	ABAT
HUMAN_PWY66-11	BMP Signalling Pathway	0.148394241417648	-1.90788275346506	1	1	0.00746268656716418	134	903	4089	SMAD4
HUMAN_PWY-3661-1	glycine betaine degradation	0.161424220671236	-1.82371946828838	5	2	0.0149253731343284	134	903	29958,6472	DMGDH,SHMT2
HUMAN_PWY-5966-1	fatty acid biosynthesis initiation	0.161424220671236	-1.82371946828838	5	2	0.0149253731343284	134	903	4706,27349	NDUFAB1,MCAT
META_COA-PWY-1	coenzyme A biosynthesis II (mammalian)	0.161424220671236	-1.82371946828838	5	2	0.0149253731343284	134	903	79646,60490	PANK3,PPCDC
HUMAN_PWY4FS-6	phosphatidylethanolamine biosynthesis II	0.161424220671236	-1.82371946828838	5	2	0.0149253731343284	134	903	55500,5833	ETNK1,PCYT2
META_PWY-6566	chondroitin biosynthesis	0.161424220671236	-1.82371946828838	5	2	0.0149253731343284	134	903	337876,55790	CHSY3,CSGALNACT1
META_PWY-3661-1	glycine betaine degradation II (mammalian)	0.161424220671236	-1.82371946828838	5	2	0.0149253731343284	134	903	29958,6472	DMGDH,SHMT2
HUMAN_COA-PWY-1	coenzyme A biosynthesis	0.161424220671236	-1.82371946828838	5	2	0.0149253731343284	134	903	60490,79646	PPCDC,PANK3
HUMAN_PWY-6352	3-phosphoinositide biosynthesis	0.199736058891796	-1.61075848955338	27	6	0.0447761194029851	134	903	5290,23396,8503,8396,23533,55361	PIK3CA,PIP5K1C,PIK3R3,PIP4K2B,PIK3R5,PI4K2A
META_PWY-7277	sphingolipid biosynthesis (mammals)	0.219412539814632	-1.51680157773951	6	2	0.0149253731343284	134	903	9517,10715	SPTLC2,CERS1
META_PWY3DJ-12	ceramide de novo biosynthesis	0.219412539814632	-1.51680157773951	6	2	0.0149253731343284	134	903	10715,9517	CERS1,SPTLC2
HUMAN_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.236813035052662	-1.44048433081221	17	4	0.0298507462686567	134	903	64419,113026,51196,5330	MTMR14,PLCD3,PLCE1,PLCB2
META_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis I	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	2618	GART
META_SER-GLYSYN-PWY	superpathway of L-serine and glycine biosynthesis I	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	6472	SHMT2
HUMAN_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	3705	ITPK1
HUMAN_PWY-6129	dolichol and dolichyl phosphate biosynthesis	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	79947	DHDDS
HUMAN_GLYSYN-PWY	glycine/serine biosynthesis	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	6472	SHMT2
HUMAN_PROPIONMET-PWY	propionyl-CoA degradation	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	5095	PCCA
HUMAN_PWY-6566	chondroitin biosynthesis	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	55790	CSGALNACT1
META_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	2618	GART
HUMAN_BETA-ALA-DEGRADATION-I-PWY	beta-alanine degradation	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	18	ABAT
META_PWY-6181	histamine degradation	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	26	AOC1
META_PWY-5030	L-histidine degradation III	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	3034	HAL
META_PWY-4041	gamma-glutamyl cycle	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	2729	GCLC
HUMAN_PWY-6118	glycerol-3-phosphate shuttle	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	2820	GPD2
META_GLUDEG-I-PWY	GABA shunt	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	18	ABAT
HUMAN_PWY-6012-1	acyl carrier protein metabolism	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	4706	NDUFAB1
HUMAN_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	2618	GART
HUMAN_GLYSYN-ALA-PWY	glycine biosynthesis	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	64902	AGXT2
HUMAN_PWY-6181	histamine degradation	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	26	AOC1
HUMAN_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	2618	GART
META_PROPIONMET-PWY	propanoyl CoA degradation I	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	5095	PCCA
META_PWY-6118	glycerol-3-phosphate shuttle	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	2820	GPD2
HUMAN_PWY-5905	hypusine biosynthesis	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	1725	DHPS
META_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.274907735482599	-1.29131974494675	2	1	0.00746268656716418	134	903	3705	ITPK1
META_PWY-6369	inositol pyrophosphates biosynthesis	0.278758445025012	-1.27740966061287	7	2	0.0149253731343284	134	903	23262,9807	PPIP5K2,IP6K1
META_DETOX1-PWY-1	reactive oxygen species degradation	0.278758445025012	-1.27740966061287	7	2	0.0149253731343284	134	903	2878,847	GPX3,CAT
HUMAN_PWY66-414	superpathway of choline degradation to L-serine	0.278758445025012	-1.27740966061287	7	2	0.0149253731343284	134	903	6472,29958	SHMT2,DMGDH
HUMAN_PWY-6369	inositol pyrophosphates biosynthesis	0.278758445025012	-1.27740966061287	7	2	0.0149253731343284	134	903	23262,9807	PPIP5K2,IP6K1
META_PWY-6368	3-phosphoinositide degradation	0.307676287285389	-1.17870706401963	19	4	0.0298507462686567	134	903	3635,64419,51763,5728	INPP5D,MTMR14,INPP5K,PTEN
META_PWY-6352	3-phosphoinositide biosynthesis	0.308249352379441	-1.17684623789872	25	5	0.0373134328358209	134	903	55361,23533,8503,5290,23396	PI4K2A,PIK3R5,PIK3R3,PIK3CA,PIP5K1C
META_PWY-5920	superpathway of heme biosynthesis from glycine	0.337795256979129	-1.08531531562137	8	2	0.0149253731343284	134	903	7390,2235	UROS,FECH
HUMAN_PWY-7434	terminal O-glycans residues modification	0.337795256979129	-1.08531531562137	8	2	0.0149253731343284	134	903	6487,10690	ST3GAL3,FUT9
HUMAN_PWY-5920	heme biosynthesis	0.337795256979129	-1.08531531562137	8	2	0.0149253731343284	134	903	7390,2235	UROS,FECH
META_PWY-7426	mannosyl-glycoprotein N-acetylglucosaminyltransferases	0.337795256979129	-1.08531531562137	8	2	0.0149253731343284	134	903	25834,11320	MGAT4C,MGAT4A
HUMAN_PWY-6368	3-phosphoinositide degradation	0.343984627079491	-1.06715831132972	20	4	0.0298507462686567	134	903	3635,64419,51763,5728	INPP5D,MTMR14,INPP5K,PTEN
META_PWY-5661	GDP-glucose biosynthesis	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	3098	HK1
HUMAN_PWY66-385	dTMP de novo biosynthesis (mitochondrial)	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	6472	SHMT2
HUMAN_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	3705	ITPK1
META_PHENYLALANINE-DEG1-PWY	L-phenylalanine degradation I (aerobic)	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	5053	PAH
HUMAN_GLUAMCAT-PWY	N-acetylglucosamine degradation I	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	51005	AMDHD2
HUMAN_HEME-BIOSYNTHESIS-II	heme biosynthesis from uroporphyrinogen-III I	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	2235	FECH
META_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	3705	ITPK1
HUMAN_GLYCLEAV-PWY	glycine cleavage	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	275	AMT
META_GLYCINE-SYN2-PWY	glycine biosynthesis II	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	275	AMT
HUMAN_PHENYLALANINE-DEG1-PWY	phenylalanine degradation/tyrosine biosynthesis	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	5053	PAH
META_PWY66-162	ethanol degradation IV	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	847	CAT
META_ASPARAGINE-DEG1-PWY-1	L-asparagine degradation III (mammalian)	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	374569	ASPG
HUMAN_GLUDEG-I-PWY	GABA shunt	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	18	ABAT
HUMAN_PWY-6100	L-carnitine biosynthesis	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	223	ALDH9A1
META_PWY-6100	L-carnitine biosynthesis	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	223	ALDH9A1
HUMAN_PWY-5661-1	GDP-glucose biosynthesis II	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	3098	HK1
HUMAN_FASYN-ELONG-PWY	fatty acid elongation -- saturated	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	4706	NDUFAB1
HUMAN_PWY-6554	1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	3705	ITPK1
META_GLYCLEAV-PWY	glycine cleavage	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	275	AMT
HUMAN_NONOXIPENT-PWY	pentose phosphate pathway (non-oxidative branch)	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	7086	TKT
META_HEME-BIOSYNTHESIS-II	heme biosynthesis I (aerobic)	0.382746096690422	-0.960383442561865	3	1	0.00746268656716418	134	903	2235	FECH
HUMAN_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.388941482085208	-0.94432637833723	15	3	0.0223880597014925	134	903	3635,51763,3705	INPP5D,INPP5K,ITPK1
META_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.388941482085208	-0.94432637833723	15	3	0.0223880597014925	134	903	51763,5728,3635	INPP5K,PTEN,INPP5D
HUMAN_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.388941482085208	-0.94432637833723	15	3	0.0223880597014925	134	903	3635,51763,5728	INPP5D,INPP5K,PTEN
META_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.388941482085208	-0.94432637833723	15	3	0.0223880597014925	134	903	3635,3705,51763	INPP5D,ITPK1,INPP5K
HUMAN_MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS	dolichyl-diphosphooligosaccharide biosynthesis	0.39531492181071	-0.92807256132538	9	2	0.0149253731343284	134	903	29929,56052	ALG6,ALG1
HUMAN_PWY66-398	TCA cycle	0.431847025016552	-0.83968386220732	16	3	0.0223880597014925	134	903	50,8803,6392	ACO2,SUCLA2,SDHD
META_PWY66-398	TCA cycle III (animals)	0.431847025016552	-0.83968386220732	16	3	0.0223880597014925	134	903	50,6392,8803	ACO2,SDHD,SUCLA2
HUMAN_PWY-7511	protein ubiquitylation	0.435259655711045	-0.831812516292612	29	5	0.0373134328358209	134	903	79876,51619,54926,10477,54476	UBA5,UBE2D4,UBE2R2,UBE2E3,RNF216
HUMAN_DETOX1-PWY-1	reactive oxygen species degradation	0.450470103775941	-0.797463566453376	10	2	0.0149253731343284	134	903	2878,847	GPX3,CAT
HUMAN_PWY66-368	ketolysis	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	622	BDH1
META_HYDROXYPRODEG-PWY	trans-4-hydroxy-L-proline degradation I	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	112817	HOGA1
META_POLYAMINSYN3-PWY	superpathway of polyamine biosynthesis II	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	113451	AZIN2
HUMAN_PWY-4261	glycerol degradation	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	2820	GPD2
HUMAN_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	51074	APIP
META_PWY-3781	aerobic respiration I (cytochrome c)	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	6392	SDHD
META_PWY-5067	glycogen biosynthesis II (from UDP-D-Glucose)	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	2992	GYG1
HUMAN_PWY-6517	N-acetylglucosamine degradation II	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	51005	AMDHD2
META_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	55191	NADSYN1
HUMAN_PWY-6755	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	51074	APIP
META_PWY-6823	molybdenum cofactor biosynthesis	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	4338	MOCS2
META_PWY66-368	ketolysis	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	622	BDH1
HUMAN_PWY66-162	ethanol degradation IV	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	847	CAT
HUMAN_SER-GLYSYN-PWY	serine and glycine biosynthesis	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	6472	SHMT2
HUMAN_THIOREDOX-PWY	thioredoxin pathway	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	10587	TXNRD2
HUMAN_HYDROXYPRODEG-PWY	4-hydroxyproline degradation	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	112817	HOGA1
HUMAN_PWY-6823	molybdenum cofactor biosynthesis	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	4338	MOCS2
HUMAN_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	55191	NADSYN1
HUMAN_PWY-2161	folate polyglutamylation	0.474648344518149	-0.745181076455316	4	1	0.00746268656716418	134	903	6472	SHMT2
HUMAN_LIPAS-PWY	triacylglycerol degradation	0.502694930795237	-0.687771792290615	11	2	0.0149253731343284	134	903	26090,3991	ABHD12,LIPE
HUMAN_PWY-6061	bile acid biosynthesis, neutral pathway	0.551641069122753	-0.594857681297331	12	2	0.0149253731343284	134	903	570,1582	BAAT,CYP8B1
HUMAN_VALDEG-PWY	valine degradation	0.551641069122753	-0.594857681297331	12	2	0.0149253731343284	134	903	3030,18	HADHA,ABAT
HUMAN_ILEUDEG-PWY	isoleucine degradation	0.551641069122753	-0.594857681297331	12	2	0.0149253731343284	134	903	36,3030	ACADSB,HADHA
META_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.552688290164428	-0.592961106970529	19	3	0.0223880597014925	134	903	3635,5728,51763	INPP5D,PTEN,INPP5K
HUMAN_PWY-5189	tetrapyrrole biosynthesis	0.552954375481063	-0.592479784514297	5	1	0.00746268656716418	134	903	7390	UROS
HUMAN_PWY66-375	leukotriene biosynthesis	0.552954375481063	-0.592479784514297	5	1	0.00746268656716418	134	903	64174	DPEP2
HUMAN_PWY66-367	ketogenesis	0.552954375481063	-0.592479784514297	5	1	0.00746268656716418	134	903	622	BDH1
HUMAN_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.552954375481063	-0.592479784514297	5	1	0.00746268656716418	134	903	7084	TK2
HUMAN_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.552954375481063	-0.592479784514297	5	1	0.00746268656716418	134	903	91373	UAP1L1
META_VALDEG-PWY	L-valine degradation I	0.552954375481063	-0.592479784514297	5	1	0.00746268656716418	134	903	18	ABAT
META_PWY-5189	tetrapyrrole biosynthesis II (from glycine)	0.552954375481063	-0.592479784514297	5	1	0.00746268656716418	134	903	7390	UROS
HUMAN_PWY-7180	2'-deoxy-alpha-D-ribose 1-phosphate degradation	0.552954375481063	-0.592479784514297	5	1	0.00746268656716418	134	903	51071	DERA
META_PWY66-375	leukotriene biosynthesis	0.552954375481063	-0.592479784514297	5	1	0.00746268656716418	134	903	64174	DPEP2
HUMAN_PWY-5030	histidine degradation	0.552954375481063	-0.592479784514297	5	1	0.00746268656716418	134	903	3034	HAL
META_PWY-4081	glutathione-peroxide redox reactions	0.552954375481063	-0.592479784514297	5	1	0.00746268656716418	134	903	2878	GPX3
META_SALVADEHYPOX-PWY	adenosine nucleotides degradation II	0.552954375481063	-0.592479784514297	5	1	0.00746268656716418	134	903	4907	NT5E
META_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.552954375481063	-0.592479784514297	5	1	0.00746268656716418	134	903	7084	TK2
HUMAN_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.5895183483572	-0.528449434201222	20	3	0.0223880597014925	134	903	3635,51763,5728	INPP5D,INPP5K,PTEN
HUMAN_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.619662742616596	-0.47857991246645	6	1	0.00746268656716418	134	903	27087	B3GAT1
HUMAN_PENTOSE-P-PWY	pentose phosphate pathway	0.619662742616596	-0.47857991246645	6	1	0.00746268656716418	134	903	7086	TKT
HUMAN_PWY-5130	2-oxobutanoate degradation	0.619662742616596	-0.47857991246645	6	1	0.00746268656716418	134	903	5095	PCCA
HUMAN_PWY-4081	glutathione redox reactions I	0.619662742616596	-0.47857991246645	6	1	0.00746268656716418	134	903	2878	GPX3
META_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.619662742616596	-0.47857991246645	6	1	0.00746268656716418	134	903	4907	NT5E
HUMAN_PWY-5996	oleate biosynthesis	0.619662742616596	-0.47857991246645	6	1	0.00746268656716418	134	903	6319	SCD
META_PWY66-367	ketogenesis	0.619662742616596	-0.47857991246645	6	1	0.00746268656716418	134	903	622	BDH1
META_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.619662742616596	-0.47857991246645	6	1	0.00746268656716418	134	903	27087	B3GAT1
META_PWY-5130	2-oxobutanoate degradation I	0.619662742616596	-0.47857991246645	6	1	0.00746268656716418	134	903	5095	PCCA
HUMAN_PWY3O-450	phosphatidylcholine biosynthesis	0.619662742616596	-0.47857991246645	6	1	0.00746268656716418	134	903	1119	CHKA
META_PWY-5972	stearate biosynthesis I (animals and fungi)	0.619662742616596	-0.47857991246645	6	1	0.00746268656716418	134	903	79071	ELOVL6
HUMAN_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.619662742616596	-0.47857991246645	6	1	0.00746268656716418	134	903	4907	NT5E
HUMAN_PWY66-374	C20 prostanoid biosynthesis	0.676480125549448	-0.390852210148083	7	1	0.00746268656716418	134	903	5742	PTGS1
META_PWY-6872	retinoate biosynthesis I	0.676480125549448	-0.390852210148083	7	1	0.00746268656716418	134	903	195814	SDR16C5
HUMAN_PWY-5067	glycogen biosynthesis	0.676480125549448	-0.390852210148083	7	1	0.00746268656716418	134	903	2992	GYG1
META_PWY66-374	C20 prostanoid biosynthesis	0.676480125549448	-0.390852210148083	7	1	0.00746268656716418	134	903	5742	PTGS1
HUMAN_PWY-5514	UDP-N-acetyl-D-galactosamine biosynthesis II	0.676480125549448	-0.390852210148083	7	1	0.00746268656716418	134	903	91373	UAP1L1
META_PWY66-399	gluconeogenesis III	0.677578770893124	-0.389229465985844	15	2	0.0149253731343284	134	903	57818,92579	G6PC2,G6PC3
HUMAN_PWY66-399	gluconeogenesis	0.677578770893124	-0.389229465985844	15	2	0.0149253731343284	134	903	92579,57818	G6PC3,G6PC2
HUMAN_PWY-6872	retinoate biosynthesis I	0.724863678204025	-0.321771671870744	8	1	0.00746268656716418	134	903	195814	SDR16C5
META_LEU-DEG2-PWY	L-leucine degradation I	0.724863678204025	-0.321771671870744	8	1	0.00746268656716418	134	903	56922	MCCC1
HUMAN_PWY-2201	folate transformations I	0.724863678204025	-0.321771671870744	8	1	0.00746268656716418	134	903	6472	SHMT2
HUMAN_SALVADEHYPOX-PWY	adenosine nucleotides degradation	0.724863678204025	-0.321771671870744	8	1	0.00746268656716418	134	903	4907	NT5E
HUMAN_PWY-5994	palmitate biosynthesis	0.724863678204025	-0.321771671870744	8	1	0.00746268656716418	134	903	4706	NDUFAB1
HUMAN_PWY-6857	retinol biosynthesis	0.744555743773142	-0.294967555553354	17	2	0.0149253731343284	134	903	8824,283848	CES2,CES4A
META_PWY-6353	purine nucleotides degradation II (aerobic)	0.766057272755363	-0.266498343426445	9	1	0.00746268656716418	134	903	4907	NT5E
META_NADSYN-PWY	NAD biosynthesis II (from tryptophan)	0.766057272755363	-0.266498343426445	9	1	0.00746268656716418	134	903	55191	NADSYN1
HUMAN_PWY3DJ-11470	sphingosine and sphingosine-1-phosphate metabolism	0.766057272755363	-0.266498343426445	9	1	0.00746268656716418	134	903	56624	ASAH2
HUMAN_PWY-7527	methionine salvage cycle III	0.766057272755363	-0.266498343426445	9	1	0.00746268656716418	134	903	51074	APIP
HUMAN_PWY-7219	adenosine ribonucleotides de novo biosynthesis	0.799338073809971	-0.223971301542461	19	2	0.0149253731343284	134	903	159,498	ADSS,ATP5A1
HUMAN_PWY-6353	purine nucleotides degradation	0.801122513754374	-0.221741392605378	10	1	0.00746268656716418	134	903	4907	NT5E
HUMAN_PWY-922	mevalonate pathway	0.801122513754374	-0.221741392605378	10	1	0.00746268656716418	134	903	4598	MVK
META_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.801122513754374	-0.221741392605378	10	1	0.00746268656716418	134	903	7084	TK2
META_PWY-922	mevalonate pathway I	0.801122513754374	-0.221741392605378	10	1	0.00746268656716418	134	903	4598	MVK
HUMAN_PWY66-407	superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle	0.807878678374322	-0.213343382261589	36	4	0.0298507462686567	134	903	50,3098,6392,8803	ACO2,HK1,SDHD,SUCLA2
HUMAN_NADSYN-PWY	NAD de novo biosynthesis	0.830965272051808	-0.185167275551313	11	1	0.00746268656716418	134	903	55191	NADSYN1
META_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.830965272051808	-0.185167275551313	11	1	0.00746268656716418	134	903	51763	INPP5K
HUMAN_PWY-5972	stearate biosynthesis	0.830965272051808	-0.185167275551313	11	1	0.00746268656716418	134	903	79071	ELOVL6
HUMAN_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	0.856358381410154	-0.155066320586496	12	1	0.00746268656716418	134	903	4598	MVK
HUMAN_LEU-DEG2-PWY	leucine degradation	0.856358381410154	-0.155066320586496	12	1	0.00746268656716418	134	903	56922	MCCC1
META_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	0.856358381410154	-0.155066320586496	12	1	0.00746268656716418	134	903	4598	MVK
META_PWY-841	superpathway of purine nucleotides de novo biosynthesis I	0.877961049081345	-0.13015304956419	13	1	0.00746268656716418	134	903	2618	GART
META_PWY-5328	superpathway of L-methionine salvage and degradation	0.877961049081345	-0.13015304956419	13	1	0.00746268656716418	134	903	5095	PCCA
HUMAN_PWY-5328	superpathway of methionine degradation	0.877961049081345	-0.13015304956419	13	1	0.00746268656716418	134	903	5095	PCCA
HUMAN_PWY66-341	cholesterol biosynthesis I	0.877961049081345	-0.13015304956419	13	1	0.00746268656716418	134	903	1718	DHCR24
HUMAN_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.877961049081345	-0.13015304956419	13	1	0.00746268656716418	134	903	1718	DHCR24
HUMAN_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.877961049081345	-0.13015304956419	13	1	0.00746268656716418	134	903	1718	DHCR24
HUMAN_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.877961049081345	-0.13015304956419	13	1	0.00746268656716418	134	903	51763	INPP5K
META_PWY-6564	heparan sulfate biosynthesis	0.87875647629884	-0.129247465985313	23	2	0.0149253731343284	134	903	266722,27087	HS6ST3,B3GAT1
HUMAN_PWY66-5	superpathway of cholesterol biosynthesis	0.906585354172801	-0.0980700952796012	25	2	0.0149253731343284	134	903	1718,4598	DHCR24,MVK
HUMAN_PWY-6564	heparan sulfate biosynthesis	0.906585354172801	-0.0980700952796012	25	2	0.0149253731343284	134	903	27087,266722	B3GAT1,HS6ST3
META_ANAEROFRUCAT-PWY	homolactic fermentation	0.911960930221546	-0.0921581294948075	15	1	0.00746268656716418	134	903	3098	HK1
HUMAN_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.911960930221546	-0.0921581294948075	15	1	0.00746268656716418	134	903	7084	TK2
META_ANAGLYCOLYSIS-PWY	glycolysis III (from glucose)	0.911960930221546	-0.0921581294948075	15	1	0.00746268656716418	134	903	3098	HK1
HUMAN_PWY66-400	glycolysis	0.911960930221546	-0.0921581294948075	15	1	0.00746268656716418	134	903	3098	HK1
HUMAN_PWY-841	purine nucleotides de novo biosynthesis	0.93146598152169	-0.0709956097129089	37	3	0.0223880597014925	134	903	498,2618,159	ATP5A1,GART,ADSS
META_PWY-6558	heparan sulfate biosynthesis (late stages)	0.936539252758043	-0.0655638436591903	17	1	0.00746268656716418	134	903	266722	HS6ST3
HUMAN_PWY-6558	heparan sulfate biosynthesis (late stages)	0.954292658019025	-0.0467848851659898	19	1	0.00746268656716418	134	903	266722	HS6ST3
HUMAN_PWY-4061	glutathione-mediated detoxification	0.954292658019025	-0.0467848851659898	19	1	0.00746268656716418	134	903	290	ANPEP
META_PWY66-5	superpathway of cholesterol biosynthesis	0.976346588634122	-0.0239376443006885	23	1	0.00746268656716418	134	903	4598	MVK
HUMAN_PWY66-409	superpathway of purine nucleotide salvage	0.98454655063509	-0.0155740984909855	38	2	0.0149253731343284	134	903	498,159	ATP5A1,ADSS
HUMAN_PWY66-401	superpathway of tryptophan utilization	0.994691335392461	-0.00532280563635242	32	1	0.00746268656716418	134	903	55191	NADSYN1
HUMAN_PWY-4821	UDP-D-xylose and UDP-D-glucuronate biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-5505	L-glutamate and L-glutamine biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_ASPARAGINE-BIOSYNTHESIS	asparagine biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-5874	heme degradation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-6482	diphthamide biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-6124	inosine-5'-phosphate biosynthesis II	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-6076	vitamin D3 biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-6124	inosine-5'-phosphate biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-6117	spermine and spermidine degradation I	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY66-397	resolvin D biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-5386	methylglyoxal degradation I	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-5481	lactate fermentation (reoxidation of cytosolic NADH)	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-6145	superpathway of CMP-sialic acids biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-5686	UMP biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-5340	sulfate activation for sulfonation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-5177	glutaryl-CoA degradation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY0-1275	lipoate biosynthesis and incorporation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-6370	ascorbate recycling (cytosolic)	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY0-1313	acetate conversion to acetyl-CoA	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY6666-2	dopamine degradation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-5670	epoxysqualene biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY66-366	flavin biosynthesis IV (mammalian)	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PROUT-PWY	L-proline degradation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-7179-1	purine deoxyribonucleosides degradation II	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_ASPARTATESYN-PWY	aspartate biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PROSYN-PWY	L-proline biosynthesis I	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY0-662	PRPP biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY0-1295	pyrimidine ribonucleosides degradation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_CHOLINE-BETAINE-ANA-PWY	choline degradation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-6	GDP-L-fucose biosynthesis II (from L-fucose)	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-7343	UDP-glucose biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY3O-4106	NAD salvage pathway III	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY66-14	MAP kinase cascade	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PLPSAL-PWY	pyridoxal 5'-phosphate salvage I	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_CYSTEINE-DEG-PWY	L-cysteine degradation I	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_GLUTAMINDEG-PWY	glutamine degradation/glutamate biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_SERDEG-PWY	L-serine degradation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-5525	D-glucuronate degradation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-5137	fatty acid beta-oxidation (unsaturated, odd number)	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-5340	sulfate activation for sulfonation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_CHOLINE-BETAINE-ANA-PWY	choline degradation I	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-6620	guanine and guanosine salvage	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY66-301	catecholamine biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-1801	formaldehyde oxidation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-6241	thyroid hormone biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY6666-1	anandamide degradation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY0-662	PRPP biosynthesis I	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_LYSINE-DEG1-PWY	lysine degradation I (saccharopine pathway)	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY66-388	fatty acid alpha-oxidation III	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-4041	gamma-glutamyl cycle	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-6370	ascorbate recycling (cytosolic)	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-7286	7-(3-amino-3-carboxypropyl)-wyosine biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-5453	methylglyoxal degradation III	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-5269	cardiolipin biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY66-397	resolvin D biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_LYSINE-DEG1-PWY	L-lysine degradation XI (mammalian)	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-0	putrescine degradation III	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-5670	epoxysqualene biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-7179-1	purine deoxyribonucleosides degradation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-2301	myo-inositol de novo biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-6620	guanine and guanosine salvage	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PROSYN-PWY	proline biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY-5806	all-trans-decaprenyl diphosphate biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY0-1182	trehalose degradation	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
HUMAN_PWY-6076	vitamin D3 biosynthesis	0.999999999997744	-2.25581359147853e-12	2	0	0	134	903
META_PWY66-161	oxidative ethanol degradation III	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-7466	acetone degradation III (to propane-1,2-diol)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-6875	retinoate biosynthesis II	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-5663	tetrahydrobiopterin de novo biosynthesis	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY66-387	fatty acid alpha-oxidation	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_2PHENDEG-PWY	phenylethylamine degradation I	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-7724	icosapentaenoate biosynthesis III (8-desaturase, mammals)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-6430	thymine degradation	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-7185	UTP and CTP dephosphorylation I	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_ARGININE-SYN4-PWY	ornithine de novo  biosynthesis	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_ADENOSYLHOMOCYSCAT-PWY	L-methionine salvage from L-homocysteine	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_METHIONINE-DEG1-PWY	methionine degradation	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY66-425	L-lysine degradation II (L-pipecolate pathway)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-7606	docosahexaenoate biosynthesis III (mammals)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY66-381	glucocorticoid biosynthesis	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY0-1296	purine ribonucleosides degradation	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-6307	tryptophan degradation via tryptamine	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-7728	(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis II (4-desaturase)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY66-381	glucocorticoid biosynthesis	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-7527	L-methionine salvage cycle III	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-7193	pyrimidine ribonucleosides salvage I	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-6318	L-phenylalanine degradation IV (mammalian, via side chain)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY66-382	mineralocorticoid biosynthesis	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY66-21	ethanol degradation II	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-4202	arsenate detoxification I (glutaredoxin)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-6405	Rapoport-Luebering glycolytic shunt	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-6609	adenine and adenosine salvage III	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY66-422	D-galactose degradation V (Leloir pathway)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_NAD-BIOSYNTHESIS-III	NAD salvage	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-6000	gamma-linolenate biosynthesis II (animals)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY66-392	lipoxin biosynthesis	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-7283	wybutosine biosynthesis	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_ARGASEDEG-PWY	L-arginine degradation I (arginase pathway)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-7049	icosapentaenoate biosynthesis II (6-desaturase, mammals)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_MALATE-ASPARTATE-SHUTTLE-PWY	L-aspartate degradation II	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY66-382	mineralocorticoid biosynthesis	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY66-221	nicotine degradation V	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-7511	protein ubiquitylation	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-5663	tetrahydrobiopterin biosynthesis I	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-7727	docosahexaenoate biosynthesis IV (4-desaturase, mammals)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-5664	tetrahydrobiopterin biosynthesis II	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-3982	uracil degradation	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-2301	myo-inositol biosynthesis	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-7177	UTP and CTP dephosphorylation II	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY66-301	catecholamine biosynthesis	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY0-1296	purine ribonucleosides degradation to ribose-1-phosphate	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_OXIDATIVEPENT-PWY-1	pentose phosphate pathway (oxidative branch)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-6609	adenine and adenosine salvage III	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY0-1295	pyrimidine ribonucleosides degradation	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-3982	uracil degradation I (reductive)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-5451	acetone degradation I (to methylglyoxal)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY66-387	fatty acid alpha-oxidation II	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-6158	creatine-phosphate biosynthesis	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-6608	guanosine nucleotides degradation	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-4202	arsenate detoxification I (glutaredoxin)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-7193	pyrimidine ribonucleosides salvage I	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-5996	oleate biosynthesis II (animals and fungi)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY0-1264	biotin-carboxyl carrier protein assembly	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY66-392	lipoxin biosynthesis	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-5331	taurine biosynthesis	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_OXIDATIVEPENT-PWY	pentose phosphate pathway (oxidative branch)	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY6666-2	dopamine degradation	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-5453	methylglyoxal degradation III	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_ADENOSYLHOMOCYSCAT-PWY	methionine salvage	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_PWY-5331	taurine biosynthesis	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
META_ARGININE-SYN4-PWY	L-ornithine biosynthesis II	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-7185	UTP and CTP dephosphorylation I	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_SAM-PWY	S-adenosyl-L-methionine biosynthesis	1.0000000000011	1.09800233141777e-12	3	0	0	134	903
HUMAN_PWY-6334	L-dopa degradation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY66-421	homocarnosine biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_GLUT-REDOX-PWY	glutathione-glutaredoxin redox reactions	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-6399	melatonin degradation II	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_BSUBPOLYAMSYN-PWY	spermidine biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-6377	alpha-tocopherol degradation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY66-388	fatty acid alpha-oxidation III	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_SERSYN-PWY	serine biosynthesis (phosphorylated route)	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-6756	S-methyl-5'-thioadenosine degradation II	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY0-1305	glutamate dependent acid resistance	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY66-420	carnosine biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-6481	L-dopachrome biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-6502	oxidized GTP and dGTP detoxification	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_GLYCGREAT-PWY	creatine biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_ALANINE-DEG3-PWY	L-alanine degradation III	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY66-366	flavin biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-7219	adenosine ribonucleotides de novo biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-6502	oxidized GTP and dGTP detoxification	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_ALANINE-DEG3-PWY	alanine biosynthesis/degradation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY0-522	lipoate salvage	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY66-420	carnosine biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-5172	acetyl-CoA biosynthesis III (from citrate)	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-6898	thiamin salvage III	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-5886	4-hydroxyphenylpyruvate biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-6133	(S)-reticuline biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_MGLDLCTANA-PWY	methylglyoxal degradation VI	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-6938	NADH repair	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_P121-PWY	adenine and adenosine salvage I	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-5905	hypusine biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-7306	estradiol biosynthesis II	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-6173	histamine biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-7112	4-hydroxy-2-nonenal detoxification	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-5766	L-glutamate degradation X	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_ARGSPECAT-PWY	spermine biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-7725	arachidonate biosynthesis V (8-detaturase, mammals)	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-6133	(S)-reticuline biosynthesis II	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-5329	L-cysteine degradation III	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-6132	lanosterol biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-5326	sulfite oxidation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY0-1021	L-alanine biosynthesis III	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-6292	superpathway of L-cysteine biosynthesis (mammalian)	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-1722	formate assimilation into 5,10-methylenetetrahydrofolate	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-7625	phosphatidylinositol biosynthesis II (eukaryotes)	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_GLUTAMATE-SYN2-PWY	glutamate biosynthesis/degradation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-6132	lanosterol biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-5120	geranylgeranyl diphosphate biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-7506	phosphatidylserine biosynthesis II	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-6173	histamine biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-5148	acyl-CoA hydrolysis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY0-1313	acetate conversion to acetyl-CoA	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-46	putrescine biosynthesis III	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-7344	UDP-D-galactose biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY66-426	hydrogen sulfide biosynthesis (trans-sulfuration)	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and transhydrogenation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-5120	geranylgeranyldiphosphate biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_SERDEG-PWY	L-serine degradation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-6377	alpha-tocopherol degradation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-5172	acetyl-CoA biosynthesis from citrate	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-6481	L-dopachrome biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-2161B	glutamate removal from folates	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-7592	arachidonate biosynthesis III (metazoa)	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY66-421	homocarnosine biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-6307	L-tryptophan degradation X (mammalian, via tryptamine)	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-7506	phosphatidylserine biosynthesis II	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY66-380	estradiol biosynthesis I (via estrone)	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_MANNCAT-PWY	D-mannose degradation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_GLUT-REDOX-PWY	glutathione redox reactions II	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-5326	sulfite oxidation IV	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-6938	NADH repair	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-7501	phosphatidylserine biosynthesis I	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-6619	adenine and adenosine salvage II	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_ASPARTATESYN-PWY	L-aspartate biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-6619	adenine and adenosine salvage VI	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-46	putrescine biosynthesis I	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_BSUBPOLYAMSYN-PWY	spermidine biosynthesis I	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PROUT-PWY	proline degradation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-5686	UMP biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY66-241	bupropion degradation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-6012-1	acyl carrier protein activation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-5269	cardiolipin biosynthesis II	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_GLNSYN-PWY	glutamine biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-7501	phosphatidylserine biosynthesis I	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_GLNSYN-PWY	L-glutamine biosynthesis I	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-5754	4-hydroxybenzoate biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-6273	phosphatidylethanolamine biosynthesis III	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_ALANINE-SYN2-PWY	L-alanine biosynthesis II	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_HOMOCYSDEGR-PWY	cysteine biosynthesis/homocysteine degradation (trans-sulfuration)	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_MGLDLCTANA-PWY	methylglyoxal degradation VI	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-5966	fatty acid biosynthesis initiation II	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_GLUTAMATE-SYN2-PWY	L-glutamate biosynthesis II	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-5329	L-cysteine degradation II	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-5754	4-hydroxybenzoate biosynthesis I (eukaryotes)	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-6756	S-methyl-5'-thioadenosine degradation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_GLYCGREAT-PWY	creatine biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY6666-1	anandamide degradation	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_PWY-6241	thyroid hormone biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-6405	Rapoport-Luebering glycolytic shunt	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY-66	GDP-L-fucose biosynthesis I (from GDP-D-mannose)	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
META_ARGSPECAT-PWY	spermine biosynthesis	1.00000000000139	1.38677958005928e-12	1	0	0	134	903
HUMAN_PWY66-21	ethanol degradation II	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
META_PWY-6030	serotonin and melatonin biosynthesis	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
META_PWY-5872	ubiquinol-10 biosynthesis (eukaryotic)	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY66-425	lysine degradation II (pipecolate pathway)	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-6875	retinoate biosynthesis II	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
META_PWY-7181	pyrimidine deoxyribonucleosides degradation	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-6030	serotonin and melatonin biosynthesis	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
META_PWY-6608	guanosine nucleotides degradation III	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-6117	spermine and spermidine degradation I	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-5874	heme degradation	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-4921	protein citrullination	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
META_PWY-6061	bile acid biosynthesis, neutral pathway	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
META_PWY-6313	serotonin degradation	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
META_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-7177	UTP and CTP dephosphorylation II	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY66-380	estradiol biosynthesis I	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-6292	cysteine biosynthesis	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_MALATE-ASPARTATE-SHUTTLE-PWY	malate-aspartate shuttle	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
META_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
META_PWY-7592	arachidonate biosynthesis III (6-desaturase, mammals)	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-7112	4-hydroxy-2-nonenal detoxification	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
META_PWY66-373	sucrose degradation V (sucrose alpha-glucosidase)	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-4984	urea cycle	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
META_PWY-7205	CMP phosphorylation	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
META_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
META_PWY-6158	creatine-phosphate biosynthesis	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
META_PWY-5994	palmitate biosynthesis I (animals and fungi)	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-5177	glutaryl-CoA degradation	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-5872	ubiquinol-10 biosynthesis	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-5659	GDP-mannose biosynthesis	1.0000000000022	2.19869337580308e-12	4	0	0	134	903
HUMAN_PWY-6111	mitochondrial L-carnitine shuttle	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
HUMAN_PWY-4983	citrulline-nitric oxide cycle	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
HUMAN_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-4984	urea cycle	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-7209	superpathway of pyrimidine ribonucleosides degradation	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-4061	glutathione-mediated detoxification I	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_CITRULBIO-PWY	L-citrulline biosynthesis	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-5651	L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
HUMAN_PWY66-378	androgen biosynthesis	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
HUMAN_PLPSAL-PWY	pyridoxal 5'-phosphate salvage	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-7726	(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis (6-desaturase)	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-4921	protein citrullination	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_TYRFUMCAT-PWY	L-tyrosine degradation I	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-6074	zymosterol biosynthesis	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
HUMAN_PWY66-241	bupropion degradation	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY66-201	nicotine degradation IV	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis I	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY66-378	androgen biosynthesis	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-4983	L-citrulline-nitric oxide cycle	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
HUMAN_PWY66-161	oxidative ethanol degradation III	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-6111	mitochondrial L-carnitine shuttle	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-6398	melatonin degradation I	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
HUMAN_PWY-7181	pyrimidine deoxyribonucleosides degradation	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-6402	superpathway of melatonin degradation	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
HUMAN_PWY66-422	D-galactose degradation V (Leloir pathway)	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
HUMAN_TYRFUMCAT-PWY	tyrosine degradation	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-6342	noradrenaline and adrenaline degradation	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-7606	docosahexaenoate biosynthesis III (6-desaturase, mammals)	1.00000000000351	3.50990533837768e-12	5	0	0	134	903
META_PWY-7229	superpathway of adenosine nucleotides de novo biosynthesis I	1.00000000000533	5.32813439602217e-12	6	0	0	134	903
META_PWY-7455	allopregnanolone biosynthesis	1.00000000000533	5.32813439602217e-12	6	0	0	134	903
META_PWY-5327	superpathway of L-lysine degradation	1.00000000000533	5.32813439602217e-12	6	0	0	134	903
META_PWY-7221	guanosine ribonucleotides de novo biosynthesis	1.00000000000533	5.32813439602217e-12	6	0	0	134	903
META_PWY66-428	L-threonine degradation V	1.00000000000533	5.32813439602217e-12	6	0	0	134	903
HUMAN_PWY-7209	pyrimidine ribonucleosides degradation	1.00000000000533	5.32813439602217e-12	6	0	0	134	903
HUMAN_PWY-7455	allopregnanolone biosynthesis	1.00000000000533	5.32813439602217e-12	6	0	0	134	903
META_ILEUDEG-PWY	L-isoleucine degradation I	1.00000000000533	5.32813439602217e-12	6	0	0	134	903
HUMAN_PWY-6313	serotonin degradation	1.00000000000533	5.32813439602217e-12	6	0	0	134	903
HUMAN_PWY-5143	fatty acid activation	1.00000000000533	5.32813439602217e-12	6	0	0	134	903
META_PWY-7176	UTP and CTP de novo biosynthesis	1.00000000000533	5.32813439602217e-12	6	0	0	134	903
HUMAN_PWY66-428	threonine degradation	1.00000000000533	5.32813439602217e-12	6	0	0	134	903
HUMAN_PWY-6074	zymosterol biosynthesis	1.00000000000533	5.32813439602217e-12	6	0	0	134	903
HUMAN_PWY66-373	sucrose degradation	1.00000000000533	5.32813439602217e-12	6	0	0	134	903
HUMAN_PWY66-221	nicotine degradation III	1.00000000000588	5.88378175810608e-12	7	0	0	134	903
META_PWY-7224	purine deoxyribonucleosides salvage	1.00000000000588	5.88378175810608e-12	7	0	0	134	903
HUMAN_PWY-5651	tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	1.00000000000588	5.88378175810608e-12	7	0	0	134	903
META_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	1.00000000000588	5.88378175810608e-12	7	0	0	134	903
META_PWY-7228	superpathway of guanosine nucleotides de novo biosynthesis I	1.00000000000757	7.56725730534252e-12	8	0	0	134	903
HUMAN_TRYPTOPHAN-DEGRADATION-1	tryptophan degradation	1.00000000000757	7.56725730534252e-12	8	0	0	134	903
HUMAN_PWY-5451	acetone degradation I (to methylglyoxal)	1.00000000000757	7.56725730534252e-12	8	0	0	134	903
META_TRYPTOPHAN-DEGRADATION-1	L-tryptophan degradation III (eukaryotic)	1.00000000000757	7.56725730534252e-12	8	0	0	134	903
HUMAN_PWY-0	putrescine degradation III	1.00000000000757	7.56725730534252e-12	8	0	0	134	903
META_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000000943	9.43293321357896e-12	9	0	0	134	903
META_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	1.00000000000943	9.43293321357896e-12	9	0	0	134	903
HUMAN_PWY-6342	noradrenaline and adrenaline degradation	1.00000000000943	9.43293321357896e-12	9	0	0	134	903
META_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis I	1.00000000000943	9.43293321357896e-12	9	0	0	134	903
HUMAN_PWY-7205	CMP phosphorylation	1.00000000000943	9.43293321357896e-12	9	0	0	134	903
META_PWY-6309	L-tryptophan degradation XI (mammalian, via kynurenine)	1.00000000000943	9.43293321357896e-12	9	0	0	134	903
HUMAN_PWY-6398	melatonin degradation I	1.00000000001066	1.06556854589311e-11	10	0	0	134	903
HUMAN_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	1.00000000001066	1.06556854589311e-11	10	0	0	134	903
HUMAN_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis	1.00000000001066	1.06556854589311e-11	10	0	0	134	903
HUMAN_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	1.00000000001066	1.06556854589311e-11	10	0	0	134	903
HUMAN_PWY66-201	nicotine degradation IV	1.00000000001066	1.06556854589311e-11	10	0	0	134	903
HUMAN_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	1.00000000001066	1.06556854589311e-11	10	0	0	134	903
HUMAN_PWY-7221	guanosine ribonucleotides de novo biosynthesis	1.00000000001206	1.20572876111175e-11	11	0	0	134	903
HUMAN_PWY-7176	UTP and CTP de novo biosynthesis	1.00000000001206	1.20572876111175e-11	11	0	0	134	903
META_PWY66-341	cholesterol biosynthesis I	1.00000000001206	1.20572876111175e-11	11	0	0	134	903
HUMAN_PWY-7224	purine deoxyribonucleosides salvage	1.00000000001206	1.20572876111175e-11	11	0	0	134	903
META_PWY66-4	cholesterol biosynthesis III (via desmosterol)	1.00000000001206	1.20572876111175e-11	11	0	0	134	903
META_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	1.00000000001206	1.20572876111175e-11	11	0	0	134	903
META_PWY-5004	superpathway of L-citrulline metabolism	1.00000000001206	1.20572876111175e-11	11	0	0	134	903
HUMAN_PWY-6309	L-kynurenine degradation	1.00000000001206	1.20572876111175e-11	11	0	0	134	903
HUMAN_PWY-6402	superpathway of melatonin degradation	1.00000000001206	1.20572876111175e-11	11	0	0	134	903
HUMAN_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000001318	1.31788260997748e-11	12	0	0	134	903
META_PWY66-391	fatty acid beta-oxidation VI (peroxisome)	1.00000000001318	1.31788260997748e-11	12	0	0	134	903
META_PWY-6857	retinol biosynthesis	1.00000000001318	1.31788260997748e-11	12	0	0	134	903
HUMAN_PWY-6000	gamma-linolenate biosynthesis	1.00000000001318	1.31788260997748e-11	12	0	0	134	903
META_PWY66-409	superpathway of purine nucleotide salvage	1.00000000001571	1.57064278845697e-11	13	0	0	134	903
HUMAN_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	1.00000000001571	1.57064278845697e-11	13	0	0	134	903
META_PWY-6861	the visual cycle I (vertebrates)	1.00000000001571	1.57064278845697e-11	13	0	0	134	903
HUMAN_PWY66-391	fatty acid beta-oxidation (peroxisome)	1.00000000001571	1.57064278845697e-11	13	0	0	134	903
META_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	1.00000000001571	1.57064278845697e-11	13	0	0	134	903
META_FAO-PWY	fatty acid beta-oxidation I	1.00000000001683	1.68342777948714e-11	14	0	0	134	903
HUMAN_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis	1.00000000001683	1.68342777948714e-11	14	0	0	134	903
HUMAN_FAO-PWY	fatty acid beta-oxidation	1.00000000001683	1.68342777948714e-11	14	0	0	134	903
HUMAN_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	1.00000000001683	1.68342777948714e-11	14	0	0	134	903
HUMAN_PWY-7228	guanosine nucleotides de novo biosynthesis	1.00000000001683	1.68342777948714e-11	14	0	0	134	903
HUMAN_PWY-6861	the visual cycle I (vertebrates)	1.00000000001891	1.89054878088658e-11	15	0	0	134	903
HUMAN_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	1.0000000000252	2.51968854321936e-11	20	0	0	134	903
